Expression of Sex Determining Region Y-Box 2 and Pancreatic and Duodenal Homeobox 1 in Pancreatic Neuroendocrine Tumors
- 1 April 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Pancreas
- Vol. 45 (4) , 522-527
Abstract
Objective The World Health Organization 2010 classification divides pancreatic neuroendocrine tumors (p-NETs) entity to well-differentiated neuroendocrine tumors (NET) and poorly differentiated neuroendocrine carcinomas (NEC) by Ki-67 index. The aim of this study is elucidate the pathophysiology and tumor biology of p-NETs. Methods We assessed the expression of transcription factors sex determining region Y-box 2 (SOX2) and pancreatic and duodenal homeobox 1 (Pdx1)) essential for the normal fetal development of pancreatic neuroendocrine cells in 46 surgically resected p-NETs by immunohistochemistry. The relationship of expression levels of these factors and clinicopathological factors were analyzed. Results SOX2 was positive in 6 p-NETs (13.0%). Five of 7 NEC patients showed positive for SOX2. SOX2 was highly (sensitivity 71%) and specifically (specificity 97%) expressed in NEC. Patients with SOX2 positive p-NET showed the significantly shorter disease-free and overall survival than patients with SOX2 negative p-NET. High Pdx1 expression was seen in 25 p-NET patients (54.3%). None of the NEC patients showed high Pdx1 expression. There was a significant reverse correlation between SOX2 and Pdx1 expression. Conclusions The expression patterns of SOX2 and Pdx1 highly correlated with prognosis of p-NETs. These expression patterns may represent the biological and pathophysiological difference of p-NETs and indicate the origin of tumor.Keywords
This publication has 22 references indexed in Scilit:
- SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinomaNature, 2014
- Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine TumorsAmerican Journal of Surgical Pathology, 2012
- DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine TumorsScience, 2011
- Expression of The Embryonic Stem Cell Transcription Factor SOX2 in Human SkinThe American Journal of Pathology, 2010
- Sox2 Expression in Brain Tumors: A Reflection of the Neuroglial Differentiation PathwayAmerican Journal of Surgical Pathology, 2008
- Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cellsNature Cell Biology, 2007
- Sox2: a possible driver of the basal-like phenotype in sporadic breast cancerLaboratory Investigation, 2007
- Vertebrate neurogenesis is counteracted by Sox1–3 activityNature Neuroscience, 2003
- Multipotent cell lineages in early mouse development depend on SOX2 functionGenes & Development, 2003
- Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancerProceedings of the National Academy of Sciences, 2000